Respiratory News and Research

RSS

Epidemic model demonstrates potential risks COVID-19 could pose for firefighting community

With wildfire season in full swing, a COVID-19 outbreak at a traditional large fire camp is a potential disaster.

5 Aug 2020

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Researchers at Uppsala University have described the presence, throughout the human body, of the enzyme ACE2.

5 Aug 2020

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

A laboratory test that has now been developed by a study group from MedUni Vienna is able to determine whether COVID-19 patients develop protective antibodies after having the disease.

5 Aug 2020

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

In a new study published on the preprint server bioRxiv researchers characterized the crystal structure of the antibody-SARS-CoV-2 RBD complex in an attempt to find the epitope and the mechanism that enables cross-neutralization.

5 Aug 2020

Embryos are susceptible to COVID-19 if mothers get sick, indicates study

Genes that are thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy, say scientists at the University of Cambridge and the California Institute of Technology (Caltech).

5 Aug 2020

Pediatric experts outline back-to-school safety guidelines for solid organ transplant recipients

As school districts look ahead to a very different school year, pediatric infectious disease experts from across the United States convened to outline back-to-school safety guidelines for solid organ transplant (SOT) recipients.

5 Aug 2020

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Now, Regeneron Pharmaceuticals says its COVID-19 antibody-drug cocktail under development prevented and treated the disease in monkeys and hamsters, showing promise that it may work in humans.

5 Aug 2020

Interleukin-6 inhibitors appear to be a more effective treatment for COVID-19

New research from Boston Medical Center found that patients experiencing severe COVID-19 symptoms had improved outcomes when administered an Interleukin-6 (IL6ri) inhibitor, sarilumab or tocilizumab, given to mediate severe systemic inflammatory responses.

5 Aug 2020

Dire COVID-19 warning from World Health Organization

The coronavirus pandemic (COVID-19) has swept across the globe, infecting more than 18 million people. With the rapid spread of the virus, the World Health Organization (WHO) warns that there might never be a “silver bullet” to combat the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

5 Aug 2020

Can Vitamin D help combat the coronavirus?

In a new report published in The Lancet, a team of researchers discussed the possibility that vitamin D could offer protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The meta-analyses of randomized controlled trials performed from 2007 to 2020.

4 Aug 2020

Photodynamic therapy can be used to fight secondary infections in COVID-19 patients

Photodynamic therapy can be an efficient ally to combat secondary infections in COVID-19 patients.

4 Aug 2020

Picomolar inhibitors to SARS-CoV-2 proteins

Now, a new study published on the preprint server bioRxiv in August 2020 reports the development of mini-inhibitors based on computational design, that are suitable for such topical use.

4 Aug 2020

Test, trace, isolate key to safe schools in COVID-19

Researchers led by Professor Kristine Maccartney from the National Centre for Immunization Research and surveillance, the Children's Hospital at Westmead and the University of Westmead, Australia explain that schools around the world have shut down to prevent the virus transmission.

4 Aug 2020

Specifically designed cyclic peptide inhibitor shown to be active against SARS-CoV-2

A new bioRxiv study by a research group from the University of California Irvine shows in vitro activity and non-toxicity of the first-in-class cyclic peptide that inhibits the main protease of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – laying the groundwork for its use in the treatment of coronavirus disease (COVID-19).

4 Aug 2020

Novel mutation identified in SARS-CoV-2 spike protein from Sweden

Researchers from Sweden and Brazil have identified a novel mutation in a strain of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) obtained from a patient in Stockholm, Sweden, in late April.

4 Aug 2020

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

Researchers in the U.S. have shown both preventive and treatment effects of an antibody cocktail in animal models of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) - the agent that causes coronavirus disease 2019 (COVID-19).

4 Aug 2020

HIIT helps achieve critical health outcomes for individuals with Down syndrome

Incorporating high-intensity interval training, or HIIT, into exercise programs for individuals with Down syndrome may help achieve critical health outcomes in a more time-efficient manner, according to an article written by researchers at the University of Georgia and Kennesaw State University.

4 Aug 2020

Study finds low rate of COVID-19 transmission in educational settings

The rate of COVID-19 transmission in New South Wales (NSW) educational settings was extremely limited during the first wave of COVID-19, research findings published today in The Lancet Child and Adolescent Health have shown.

4 Aug 2020

Yale researchers develop new mouse model to study SARS-CoV-2 infection

Researchers at Yale University School of Medicine have developed a new mouse model to study SARS-CoV-2 infection and disease and to accelerate testing of novel treatments and vaccines against the novel coronavirus.

4 Aug 2020

Severe vitamin D deficiency in UK South Asian population can lead to health problems

20 percent of the middle-aged UK South Asian population may have a very severe vitamin D deficiency, a new study in the British Journal of Nutrition reports. Such deficiency can lead to health problems such as osteomalacia (softening of the bones) and other chronic diseases.

4 Aug 2020

Respiratory News and Research

Epidemic model demonstrates potential risks COVID-19 could pose for firefighting community

Study provides comprehensive update on ACE2 enzyme with key role in SARS-CoV-2 infection

Laboratory test shows only 60% of COVID-19 patients develop protective antibodies

Avidity of binding responsible for cross-neutralization of SARS-CoV-1 and SARS-CoV-2

Embryos are susceptible to COVID-19 if mothers get sick, indicates study

Pediatric experts outline back-to-school safety guidelines for solid organ transplant recipients

Regeneron's COVID-19 antibody-drug cocktail treats SARS-CoV-2 virus in animals

Interleukin-6 inhibitors appear to be a more effective treatment for COVID-19

Dire COVID-19 warning from World Health Organization

Can Vitamin D help combat the coronavirus?

Photodynamic therapy can be used to fight secondary infections in COVID-19 patients

Picomolar inhibitors to SARS-CoV-2 proteins

Test, trace, isolate key to safe schools in COVID-19

Specifically designed cyclic peptide inhibitor shown to be active against SARS-CoV-2

Novel mutation identified in SARS-CoV-2 spike protein from Sweden

Regeneron antibody cocktail shows promise as potential COVID-19 treatment

HIIT helps achieve critical health outcomes for individuals with Down syndrome

Study finds low rate of COVID-19 transmission in educational settings

Yale researchers develop new mouse model to study SARS-CoV-2 infection

Severe vitamin D deficiency in UK South Asian population can lead to health problems

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News